Why is Solara Active falling/rising?

As of 11-Aug, Solara Active Pharma Sciences Ltd is experiencing a price increase, currently at Rs 592.30, which reflects a rise of 11.2 points or 1.93%. Today's performance shows that the stock has outperformed its sector by 1.02%, reaching an intraday high of Rs 594.05. However, the stock has shown a decline of 3.76% over the past week and a more significant drop of 10.54% over the past month. Despite these short-term declines, the company has reported very positive results, including a 16.9% growth in net sales and a substantial increase in profit before tax, which has grown by 590.5%. The stock is trading at a discount compared to its peers, and its attractive valuation is supported by a PEG ratio of 0.8. However, concerns remain regarding its long-term fundamental strength, highlighted by a -7.45% CAGR growth in operating profits over the last five years and a high debt to EBITDA ratio.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has only declined by 0.51% over the past week. While Solara's short-term returns are negative, its long-term performance over three years shows a significant gain of 71%, compared to the Sensex's 35.85%. This indicates that while the stock may be facing short-term challenges, its historical performance suggests potential resilience. Nonetheless, the high percentage of pledged promoter shares and the company's low return on equity may weigh on investor sentiment, contributing to volatility in its stock price.